Stock screenerAll disclosures →
EDGAR →
TEVA
Conviction 73HealthcareScan · Thu, Jun 25, 2026TEVA$33.59-1.86%
ResistanceSupportVol 14Insider sell3
Vol MA14 6.68M
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price33.59
Change-1.86%
Gap-0.22%
Rel volume1.70×
Avg volume7.07M
Avg $ vol238.27M
SMA 2033.67
SMA 5033.80
SMA 20029.05
Price vs 50-0.63%
Price vs 200+15.63%
MA stackmixed
50/200 cross—
Supertrenddown · 35.20
RSI (14)50
MACD hist-0.04
MACD cross—
Stoch %K / %D63 / 65
ADX (14)12
+DI / −DI26 / 23
RSI divergence—
MACD divergenceBullish
ATR %+3.57%
ADR %3.48%
52w high36.34
52w low15.38
From 52w high-7.58%
Above 52w low+118.37%
New 52w highNo
SqueezeOff
Bollinger width11.29%
%B0.48
Donchian pos59.64%
Donchian high35.47
Donchian low30.80
AVWAP (52w high)33.00
vs AVWAP high+1.76%
AVWAP (52w low)26.86
vs AVWAP low+25.02%
OBV trendFlat
Chaikin MF (20)0.12
Today vs 20d1.70×
Avg vol (14d)6.68M
Avg vol (20d)7.07M
Avg $ vol (20d)238.27M
Market cap39.11B
RS 3m (vs SPY)+5.18%
RS 6m (vs SPY)+5.02%
RS line new highNo
Trend template7/8
Technical rank60.2
1 week+3.15%
1 month-2.96%
3 months+14.00%
6 months+7.61%
1 year+96.52%
YTD+8.51%
P/E27.74
P/B4.75
P/S2.27
P/FCF35.52
EPS1.21
Div yield0.03%
ROE17.14%
ROA3.52%
Debt/Eq3.82
Current1.01
EV/EBITDA21.14
Gross margin51.79%
Net margin8.17%
Rev growth4.32%
EPS growth186.03%
Price target42.38
Target upside26.19%
Analyst ratingBuy
Institutional61.45%
Ent. value66.8B
Revenue3.98B
Net income369M
Gross profit1.97B
Free cash flow1.1B
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNYSE
Shares out1.16B
Employees32.84K
ListedTue, Feb 16, 1982
Free float540.72M
Float %46.4%
Short interest33.87M
Days to cover6.0d
Short volume47.0%
Squeeze score53 / 100
Next earningsWed, Jul 29, 2026 · pre-mkt (34d)
EPS forecast$0.37 · 2 est
Last EPS vs est$0.50 vs $0.49
Last surprise+2.0% beat
Setup gradeB
Conviction73 / 100
Pattern quality—
Tech rank60.2 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance36.23
Support31.59
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in TEVA
No recent disclosed trades by Congress in TEVA. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in TEVA · 4 buys · 5 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Shields Matthew EVP, Global Operations · Ordinary Shares · 2026-06-18 | Sell | 9.99K | $322K | 2026-06-18 | 2026-06-22 |
Crane Rosemary A Director · Ordinary Shares · 2026-06-05 | Exercise | 14.49K | — | 2026-06-05 | 2026-06-08 |
Elstein Amir Director · Ordinary Shares · 2026-06-05 | Exercise | 14.49K | — | 2026-06-05 | 2026-06-08 |
Satchi-Fainaro Ronit Director · Ordinary Shares · 2026-06-05 | Exercise | 14.49K | — | 2026-06-05 | 2026-06-08 |
Lichtenstein Chen Director · Ordinary Shares · 2026-06-05 | Exercise | 14.49K | — | 2026-06-05 | 2026-06-08 |
Nisen Perry Director · Restricted Share Units · 2026-06-05 | Exercise | 14.49K | $0 | 2026-06-05 | 2026-06-08 |
MIGNONE ROBERTO Director · Ordinary Shares · 2026-06-05 | Other | — | — | 2026-06-05 | 2026-06-08 |
Lichtenstein Chen Director · Restricted Share Units · 2026-06-05 | Exercise | 14.49K | $0 | 2026-06-05 | 2026-06-08 |
Francis Richard D President and CEO · Restricted Share Units · 2026-06-05 | Exercise | 13.04K | $0 | 2026-06-05 | 2026-06-08 |
BARER SOL J Director · Restricted Share Units · 2026-06-05 | Exercise | 21.74K | $0 | 2026-06-05 | 2026-06-08 |
SEC filings
EDGAR filings in TEVA · 4 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.